Loading...
Pretreatment (18)F‐FDG Uptake Heterogeneity Predicts Treatment Outcome of First‐Line Chemotherapy in Patients with Metastatic Triple‐Negative Breast Cancer
BACKGROUND. Intratumoral heterogeneity of (18)F‐fluorodeoxyglucose ((18)F‐FDG) uptake in primary tumor has proven to be a surrogate marker for predicting treatment outcome in various tumors. However, the value of intraindividual heterogeneity in metastatic diseases remains unknown. The aim of this s...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6263118/ https://ncbi.nlm.nih.gov/pubmed/30082489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|